PL385589A1 - Wykrywanie podwyższonej podatności na chemioterapię z zastosowaniem cytostatyków platynowych - Google Patents
Wykrywanie podwyższonej podatności na chemioterapię z zastosowaniem cytostatyków platynowychInfo
- Publication number
- PL385589A1 PL385589A1 PL385589A PL38558908A PL385589A1 PL 385589 A1 PL385589 A1 PL 385589A1 PL 385589 A PL385589 A PL 385589A PL 38558908 A PL38558908 A PL 38558908A PL 385589 A1 PL385589 A1 PL 385589A1
- Authority
- PL
- Poland
- Prior art keywords
- existence
- detection
- side effects
- increased risk
- chemotherapy side
- Prior art date
Links
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 title 2
- 238000002512 chemotherapy Methods 0.000 title 1
- 239000000824 cytostatic agent Substances 0.000 title 1
- 230000001085 cytostatic effect Effects 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 229910052697 platinum Inorganic materials 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL385589A PL212012B1 (pl) | 2008-07-06 | 2008-07-06 | Wykrywanie podwyższonej podatności na chemioterapię z zastosowaniem cytostatyków platynowych |
| PCT/PL2009/050011 WO2010005329A2 (en) | 2008-07-06 | 2009-07-06 | Fast assignment of adequate chemotherapy with platinum based drugs for cancer patients based on the identification of constitutional brcal mutations |
| US12/996,827 US20110245095A1 (en) | 2008-07-06 | 2009-07-06 | Fast assignment of adequate chemotherapy with latinum based drugs for cancer patients based on the identification of constitutional brcal mutations |
| EP09788418A EP2310535A2 (en) | 2008-07-06 | 2009-07-06 | Fast assignment of adequate chemotherapy with platinum based drugs for cancer patients based on the identification of constitutional brcal mutations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL385589A PL212012B1 (pl) | 2008-07-06 | 2008-07-06 | Wykrywanie podwyższonej podatności na chemioterapię z zastosowaniem cytostatyków platynowych |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL385589A1 true PL385589A1 (pl) | 2010-01-18 |
| PL212012B1 PL212012B1 (pl) | 2012-07-31 |
Family
ID=41443872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL385589A PL212012B1 (pl) | 2008-07-06 | 2008-07-06 | Wykrywanie podwyższonej podatności na chemioterapię z zastosowaniem cytostatyków platynowych |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20110245095A1 (pl) |
| EP (1) | EP2310535A2 (pl) |
| PL (1) | PL212012B1 (pl) |
| WO (1) | WO2010005329A2 (pl) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0226595D0 (en) * | 2002-11-15 | 2002-12-24 | Univ Belfast | Cancer therapy determination |
| EP2018439A1 (en) * | 2006-04-24 | 2009-01-28 | Epiontis GmbH | Personalizing cancer chemotherapy based on methylation and germ-line mutational analysis of brca-1 |
| PL217731B1 (pl) * | 2006-06-01 | 2014-08-29 | Tomasz Byrski | Sposób wykrywania genetycznie uwarunkowanej obniżonej odpowiedzi na chemioterapię cytostatykiem taksanowym, zastosowanie mutacji założycielskiej oraz zestawu do wykrywania takiej odpowiedzi |
-
2008
- 2008-07-06 PL PL385589A patent/PL212012B1/pl unknown
-
2009
- 2009-07-06 EP EP09788418A patent/EP2310535A2/en not_active Withdrawn
- 2009-07-06 US US12/996,827 patent/US20110245095A1/en not_active Abandoned
- 2009-07-06 WO PCT/PL2009/050011 patent/WO2010005329A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2310535A2 (en) | 2011-04-20 |
| WO2010005329A2 (en) | 2010-01-14 |
| WO2010005329A3 (en) | 2010-03-11 |
| PL212012B1 (pl) | 2012-07-31 |
| US20110245095A1 (en) | 2011-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2456567B (en) | Novelty detection | |
| GB2477680B (en) | Detecting concealed threats | |
| BRPI0914657A2 (pt) | piridin-2-onae piridazin-3-onas substituídas | |
| BRPI0922461A2 (pt) | superfície do estabilizador horizontal de aeronave. | |
| IL227406A0 (en) | Pyrimidine gyrase and topoisomerase inhibitors and their uses | |
| GB2498697B (en) | Flow measurement | |
| GB2491935B (en) | Nickel-silicide formation with differential Pt composition | |
| BR112012033194A2 (pt) | composição de fluído funcional | |
| GB2493894B (en) | Fluid resistivity sensor | |
| EP2257831A4 (en) | DETECTION OF AN ENTITY IN MOTION | |
| GB2482666B (en) | Chemical sensor | |
| GB2499167B (en) | Flow measurement | |
| FI20100404A0 (fi) | Yhteysalus | |
| GB201021711D0 (en) | Assay | |
| EP2583066A4 (en) | FLOW SENSOR | |
| GB201004306D0 (en) | Assay | |
| GB201002382D0 (en) | Assay | |
| GB201012078D0 (en) | Concentration measurement using luminescene | |
| DK2257292T3 (da) | Kombinationsterapi med Zn/trimethoprim | |
| PL385589A1 (pl) | Wykrywanie podwyższonej podatności na chemioterapię z zastosowaniem cytostatyków platynowych | |
| EP2317180A4 (de) | Abik-differential | |
| FIU20100501U0 (fi) | Yhteysalus | |
| EP2581709A4 (en) | RESISTIVE SUBSTRATE FOR SENSOR | |
| GB201006516D0 (en) | Polorific mkc 2 | |
| AU2010902357A0 (en) | Flow Measurement |